Daily Intravoxel Incoherent Motion (IVIM) In Prostate Cancer Patients During MR-Guided Radiotherapy-A Multicenter Study.
Loading...
Embargo End Date
ICR Authors
Authors
Kooreman, ES
van Houdt, PJ
Keesman, R
van Pelt, VWJ
Nowee, ME
Pos, F
Sikorska, K
Wetscherek, A
Müller, A-C
Thorwarth, D
Tree, AC
van der Heide, UA
van Houdt, PJ
Keesman, R
van Pelt, VWJ
Nowee, ME
Pos, F
Sikorska, K
Wetscherek, A
Müller, A-C
Thorwarth, D
Tree, AC
van der Heide, UA
Document Type
Journal Article
Date
2021-08-13
Date Accepted
2021-07-16
Abstract
PURPOSE: Daily quantitative MR imaging during radiotherapy of cancer patients has become feasible with MRI systems integrated with linear accelerators (MR-linacs). Quantitative images could be used for treatment response monitoring. With intravoxel incoherent motion (IVIM) MRI, it is possible to acquire perfusion information without the use of contrast agents. In this multicenter study, daily IVIM measurements were performed in prostate cancer patients to identify changes that potentially reflect response to treatment. MATERIALS AND METHODS: Forty-three patients were included, treated with 20 fractions of 3 Gy on a 1.5 T MR-linac. IVIM measurements were performed on each treatment day. The diffusion coefficient (D), perfusion fraction (f), and pseudo-diffusion coefficient (D*) were calculated based on the median signal intensities in the non-cancerous prostate and the tumor. Repeatability coefficients (RCs) were determined based on the first two treatment fractions. Separate linear mixed-effects models were constructed for the three IVIM parameters. RESULTS: In total, 726 fractions were analyzed. Pre-treatment average values, measured on the first fraction before irradiation, were 1.46 × 10-3 mm2/s, 0.086, and 28.7 × 10-3 mm2/s in the non-cancerous prostate and 1.19 × 10-3 mm2/s, 0.088, and 28.9 × 10-3 mm2/s in the tumor, for D, f, and D*, respectively. The repeatability coefficients for D, f, and D* in the non-cancerous prostate were 0.09 × 10-3 mm2/s, 0.05, and 15.3 × 10-3 mm2/s. In the tumor, these values were 0.44 × 10-3 mm2/s, 0.16, and 76.4 × 10-3 mm2/s. The mixed effects analysis showed an increase in D of the tumors over the course of treatment, while remaining stable in the non-cancerous prostate. The f and D* increased in both the non-cancerous prostate and tumor. CONCLUSIONS: It is feasible to perform daily IVIM measurements on an MR-linac system. Although the repeatability coefficients were high, changes in IVIM perfusion parameters were measured on a group level, indicating that IVIM has potential for measuring treatment response.
Citation
Frontiers in Oncology, 2021, 11 pp. 705964 -
Source Title
Frontiers in Oncology
Publisher
FRONTIERS MEDIA SA
ISSN
2234-943X
eISSN
2234-943X
2234-943X
2234-943X
Collections
Research Team
Magnet Resonance Imaging